China Resources Sanjiu Medical & Pharmaceutical Co Ltd (000999) — Cash Flow-to-Debt Ratio
China Resources Sanjiu Medical & Pharmaceutical Co Ltd (000999) has a Cash Flow-to-Debt Ratio of 0.01x as of September 2025, meaning its operating cash flow of CN¥126.71 Million could theoretically repay 0% of its total liabilities (CN¥19.18 Billion) in one year. See China Resources Sanjiu Medical & Pharmac free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
China Resources Sanjiu Medical & Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio (1999–2024)
Historical debt coverage capacity for China Resources Sanjiu Medical & Pharmaceutical Co Ltd across 26 annual periods. Also explore 000999 net assets growth trend to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for China Resources Sanjiu Medical & Pharmaceutical Co Ltd (1999–2024)
Year-by-year debt coverage analysis for China Resources Sanjiu Medical & Pharmaceutical Co Ltd. For market capitalisation and broader financial context, see China Resources Sanjiu Medical & Pharmac market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.30x | CN¥4.40 Billion | CN¥14.83 Billion | ▲ +11.8% |
| 2023 | 0.27x | CN¥4.22 Billion | CN¥15.89 Billion | ▼ -15.3% |
| 2022 | 0.31x | CN¥3.01 Billion | CN¥9.59 Billion | ▲ +44.1% |
| 2021 | 0.22x | CN¥1.87 Billion | CN¥8.60 Billion | ▼ -22.2% |
| 2020 | 0.28x | CN¥2.22 Billion | CN¥7.95 Billion | ▲ +2.4% |
| 2019 | 0.27x | CN¥1.97 Billion | CN¥7.22 Billion | ▼ -2.0% |
| 2018 | 0.28x | CN¥1.91 Billion | CN¥6.86 Billion | ▲ +8.4% |
| 2017 | 0.26x | CN¥1.56 Billion | CN¥6.07 Billion | ▼ -10.8% |
| 2016 | 0.29x | CN¥1.39 Billion | CN¥4.83 Billion | ▼ -0.6% |
| 2015 | 0.29x | CN¥1.26 Billion | CN¥4.35 Billion | ▼ -10.1% |
| 2014 | 0.32x | CN¥1.18 Billion | CN¥3.67 Billion | ▼ -14.7% |
| 2013 | 0.38x | CN¥1.47 Billion | CN¥3.88 Billion | ▼ -5.3% |
| 2012 | 0.40x | CN¥1.21 Billion | CN¥3.04 Billion | ▲ +14.9% |
| 2011 | 0.35x | CN¥954.90 Million | CN¥2.75 Billion | ▼ -33.3% |
| 2010 | 0.52x | CN¥848.28 Million | CN¥1.63 Billion | ▲ +2.4% |
| 2009 | 0.51x | CN¥855.05 Million | CN¥1.68 Billion | ▼ -25.3% |
| 2008 | 0.68x | CN¥1.12 Billion | CN¥1.64 Billion | ▲ +450.3% |
| 2007 | 0.12x | CN¥605.30 Million | CN¥4.89 Billion | ▲ +31.2% |
| 2006 | 0.09x | CN¥425.51 Million | CN¥4.51 Billion | ▲ +1822.7% |
| 2005 | 0.00x | CN¥22.83 Million | CN¥4.65 Billion | ▲ +103.3% |
| 2004 | -0.15x | CN¥-719.63 Million | CN¥4.89 Billion | ▼ -2825.3% |
| 2003 | 0.01x | CN¥28.09 Million | CN¥5.20 Billion | ▼ -95.7% |
| 2002 | 0.13x | CN¥496.12 Million | CN¥3.95 Billion | ▲ +198.7% |
| 2001 | 0.04x | CN¥153.44 Million | CN¥3.65 Billion | ▼ -54.1% |
| 2000 | 0.09x | CN¥266.86 Million | CN¥2.91 Billion | ▼ -29.6% |
| 1999 | 0.13x | CN¥120.63 Million | CN¥925.96 Million | — |